Are you worried about the cost? CDC offers free or low-cost mammograms. Find out if you qualify.
Last Posted: Dec 06, 2018
- A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study.
Nunziato Marcella et al. Analytica chimica acta 2019 Jan 1046154-162 - A Proposed Approach for Implementing Genomics-Based Screening Programs for Healthy Adults
M. Murray and the Genomics and Population Health Action Collaborative, National Academies of Medicine, December 3, 2018 - Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors.
Reblin Maija et al. The breast journal 2018 Nov - Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Frey Melissa K et al. Cancer 2018 Nov - Risk and prognostic factors for endometrial carcinoma after diagnosis of breast or Lynch-associated cancers-A population-based analysis.
Johnatty Sharon E et al. Cancer medicine 2018 Nov - Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk.
Terry Mary Beth et al. Journal of the National Cancer Institute 2018 Nov - Uterine cancer in Jewish Israeli BRCA1/BRCA2 mutation carriers.
Laitman Yael et al. Cancer 2018 Nov - The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients.
Bernstein-Molho Rinat et al. Cancer causes & control : CCC 2018 Nov - [Making better use of the clinical geneticist's expertise; treating physician could request a DNA test for most cancer patients].
Aalfs C M et al. Nederlands tijdschrift voor geneeskunde 2017 161(0) D1525 - A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy.
Qian Jun et al. Scientific reports 2017 745828
.jpg)
No hay comentarios:
Publicar un comentario